EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Graphene-plasmonic nanoparticle hybrid sensor platforms for vitamin D detection

Kiki Chan, Nur Azura Mohd Said, Siok Fong Chin, Amaramalar Selvi Naicker, Suzana Makpol, Kin Chun Wong, Hanis Yasmin Sofian, Farhanulhakim Mohd Razip Wee, P Susthitha Menon

Nano TransMed · 2026-12 · 5 · 100118

DOI: 10.1016/j.ntm.2026.100118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano TransMed, 2026-12. Verfasst von Kiki Chan und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education, Malaysia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate quantification of serum 25-hydroxyvitamin D [25(OH)D], the principal biomarker of vitamin D status, is essential to prevent deficiency and supplementation-induced toxicity. Despite widespread clinical use, immunoassays and LC-MS/MS remain centralised and instrumentation-intensive, limiting scalable point-of-care deployment. Clinically meaningful assessment requires reliable measurement across the 10-150 ng/mL range in protein-rich serum, where 25(OH)D is predominantly vitamin D-binding protein (VDBP)-bound and intrinsically electrochemically and optically inert. These constraints sustain a translational gap between analytical sensitivity and deployable testing. Although biosensor platforms have emerged as alternatives, many prioritise ultra-low limits of detection without equivalent consideration of matrix tolerance, calibration robustness, or fabrication reproducibility. Graphene enhances surface accessibility and charge transport, while plasmonic nanostructures amplify local electromagnetic fields. In hybrid architectures, this mechanistic synergy enables coupled electron-transfer modulation and plasmon-enhanced signal amplification, addressing core limitations of small-molecule detection. This review synthesises graphene, plasmonic, and graphene-plasmonic platforms for 25(OH)D sensing, emphasising interfacial mechanisms, functionalisation strategies, analytical performance relative to clinical thresholds, and translational feasibility. Key challenges in matrix resilience, reproducibility, and reference-method benchmarking are delineated to establish design criteria for clinically deployable vitamin D diagnostics. • Graphene-plasmonic hybrids enable ultrasensitive vitamin D₃ biosensing • Charge and field coupling amplify electrochemical and optical responses • Aptamer-nanohybrid interfaces achieve selective 25(OH)D₃ recognition • Simulation-guided co-design improves reproducibility and scalability • Review outlines translational path for hybrid nanobiosensor deployment

Förderung

  • Ministry of Higher Education, Malaysia

Zitieren

APA

Chan, K., Said, N. A. M., Chin, S. F., Naicker, A. S., Makpol, S., Wong, K. C., Sofian, H. Y., Wee, F. M. R., & Menon, P. S. (2026). Graphene-plasmonic nanoparticle hybrid sensor platforms for vitamin D detection. Nano TransMed, 5, 100118. https://doi.org/10.1016/j.ntm.2026.100118

Vancouver

Chan K, Said NAM, Chin SF, Naicker AS, Makpol S, Wong KC, et al. Graphene-plasmonic nanoparticle hybrid sensor platforms for vitamin D detection. Nano TransMed. 2026;5:100118. doi:10.1016/j.ntm.2026.100118

BibTeX
@article{Chan2026,
  author = {Chan, Kiki and Said, Nur Azura Mohd and Chin, Siok Fong and Naicker, Amaramalar Selvi and Makpol, Suzana and Wong, Kin Chun and Sofian, Hanis Yasmin and Wee, Farhanulhakim Mohd Razip and Menon, P Susthitha},
  title = {Graphene-plasmonic nanoparticle hybrid sensor platforms for vitamin D detection},
  journal = {Nano TransMed},
  year = {2026},
  volume = {5},
  pages = {100118},
  doi = {10.1016/j.ntm.2026.100118}
}
Kostenlos starten →